Physician profile
David Blank
NPI 1013996974
$1,903.80
in general payments reported to CMS, 2019-2025
18 companies · $236 in 2025
The $236 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $91.86 · 2021: $351 · 2022: $210 · 2023: $282 · 2024: $310 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $466.51 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Sanofi Pasteur INC. | $238.22 | 2022-2025 | |
| Pfizer INC. | $224.33 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $206.14 | 2019-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Tris Pharma INC | $128.47 | 2019-2025 | Dyanavel Xr |
| Neos Therapeutics, Lp | $117.87 | 2019-2020 | |
| Cranial Technologies, INC | $117.63 | 2021-2025 | Doc Band |
| Abbvie INC. | $107.12 | 2019 | |
| Genzyme Corporation | $100.14 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $39.38 | 2024 | Flumist Quadrivalent |
| Kyowa Kirin, INC. | $26.12 | 2023 | Crysvita |
| Alexion Pharmaceuticals, INC. | $24.03 | 2023 | Koselugo |
| Novo Nordisk INC | $23.73 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $23.08 | 2021 | |
| Sarepta Therapeutics, INC. | $21.28 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $14.30 | 2019 | |
| Kaleo, INC. | $12.95 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Blank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.